Dr Luca Toschi, formerly a member of PRECISION ONCOLOGY CONNECT and now a leading member of LUNG CONNECT, developed this resource with COR2ED.
Dr Luca Toschi, formerly a member of PRECISION ONCOLOGY CONNECT and now a leading member of LUNG CONNECT, developed this resource with COR2ED.
AstraZeneca, BMS, Boehringer, Ingelheim, Lilly, MSD, Pfizer and Roche.
Medical experts discuss treatment strategies and sequencing after ET + CDK4/6i for ER+/HER2- metastatic breast cancer
Αναλύσεις από καταξιωμένους ειδικούς ιατρούς. Πλοηγηθείτε στις καρτέλες για να επιλέξετε ένα επεισόδιο podcast
How will the latest Dato-DXd data impact treatment strategies for HR+/HER2− mBC?
Understanding the role of molecular subtypes in guiding treatment selection
Uznani eksperci dzielą się swoimi spostrzeżeniami. Kliknij na odpowiednią zakładkę, aby wybrać odcinek podcastu.